Discover 1 curated intelligence briefings related to this specific topic.
The landscape of oncology is shifting. No longer relying on the blunt force of systemic chemotherapy, the medical world is pivoting toward Antibody-Drug Conjugates (ADCs)—precision-engineered biological missiles that deliver cytotoxic payloads directly to malignant cells while sparing healthy tissue.
